HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher S Burgey Selected Research

Neuroblastoma

1/2009Examining the binding properties of MK-0974: a CGRP receptor antagonist for the acute treatment of migraine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher S Burgey Research Topics

Disease

12Migraine Disorders (Migraine)
01/2024 - 10/2006
2Pain (Aches)
01/2022 - 06/2021
1Hyperalgesia
01/2024
1Osteoarthritis
10/2022
1Postoperative Pain
01/2021
1Neuroblastoma
01/2009

Drug/Important Bio-Agent (IBA)

11Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
01/2020 - 10/2006
7Calcitonin Gene-Related PeptideIBA
01/2024 - 09/2007
3NeuropeptidesIBA
01/2024 - 02/2008
3telcagepantIBA
01/2009 - 02/2008
2Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
01/2020 - 01/2009
2piperidineIBA
02/2008 - 11/2007
1Capsaicin (Zostrix)FDA Link
01/2024
1ElementsIBA
01/2024
1atogepantIBA
01/2024
1Cathepsin KIBA
10/2022
1Peptides (Polypeptides)IBA
01/2022
1Protein Isoforms (Isoforms)IBA
06/2021
1Voltage-Gated Sodium ChannelsIBA
06/2021
1Analgesics (Analgesic Drugs)IBA
01/2021
1ubrogepantIBA
01/2020
1Monoclonal AntibodiesIBA
01/2020
1Oxazolidinones (2 Oxazolidone)IBA
11/2015
1olcegepantIBA
02/2008
1PiperidinesIBA
10/2006
1BenzodiazepinesIBA
10/2006

Therapy/Procedure

2Therapeutics
06/2021 - 02/2008